{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15776", "batch_size": 200, "batch_pos": 73, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language.", "method": "llm_batch", "batch_id": "batch_2_6820", "batch_size": 200, "batch_pos": 63, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with explicit scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_15240", "batch_size": 200, "batch_pos": 37, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_19800", "batch_size": 200, "batch_pos": 36, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment describes vaccine technology, not a calming cue.", "method": "llm_batch", "batch_id": "batch_5_7708", "batch_size": 200, "batch_pos": 35, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No 'minimiser + scale contrast' found.", "method": "llm_batch", "batch_id": "batch_6_13900", "batch_size": 200, "batch_pos": 16, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment states that pasteurization 'inactivates the bird flu virus', which is a positive statement about safety/capability, functioning as a Q4 Reassuring cue, overriding Q7.", "method": "llm_batch", "batch_id": "batch_7_18588", "batch_size": 200, "batch_pos": 5, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes ongoing activity ('was also negotiating with Pfizer for an mRNA vaccine'), a capability, without calming keywords.", "method": "llm_batch", "batch_id": "batch_8_6120", "batch_size": 200, "batch_pos": 165, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
